IT Director
Kymera Therapeutics
IT Director
Kymera Therapeutics
Biotech company engineering targeted protein degraders
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn.
Kymera is seeking an IT Director, Development Business Partner to serve as the senior IT leader embedded within the Development organization. This is a high-impact, strategic role for someone who has navigated the full arc of clinical-stage growth: from early-phase trials through Phase 3, NDA submission, and commercialization. The ideal candidate brings deep expertise in development technology, hands-on experience with Veeva Vault, a strong command of validated systems and regulatory requirements, and the vision to reimagine what those systems and processes can look like in the age of AI.
Reporting to the Senior Director of IT Applications, this person will own the technology strategy and execution across the Development portfolio, build trusted partnerships with Clinical Operations, Clinical/Medical Development, Quality, Biometrics, Data Management, Regulatory, and more, and serve as a thought partner to the IT leadership team as Kymera scales.
Kymera Therapeutics is proud to be an equal opportunity employer, seeking to create a welcoming and diverse environment. All applicants will receive consideration for employment without regard to race, color, religion, creed, gender, national origin, age, disability, veteran status, pregnancy, sex, marital status, gender expression or identity, genetic information, sexual orientation, citizenship, or any other legally protected class.
Compensation
Biotech company engineering targeted protein degraders
Kymera Therapeutics develops therapies that remove disease-causing proteins using targeted protein degradation. The company’s Pegasus Platform helps identify which proteins to degrade and then uses molecules that recruit the cell’s waste machinery to break down those proteins, aiming to treat cancers and immune diseases. This approach can create multiple drug candidates across different diseases. Kymera’s products are advanced through collaborations, most notably with Sanofi, which supports research, licensing, and milestone-based payments. Unlike traditional drugs that inhibit a protein’s function, Kymera’s strategy eliminates the protein itself, potentially offering new treatment options for patients. The company’s goal is to deliver new, effective medicines by degrading harmful proteins, expanding options in the biopharmaceutical market and addressing unmet medical needs.
Explore more opportunities at Kymera Therapeutics